Future directions in hemostasis: Normalizing the lives of patients with hemophilia-Reference-Cited by-同舟云学术

Future directions in hemostasis: Normalizing the lives of patients with hemophilia

Published:2010-04 Issue: Volume:125 Page:S78-S81
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Carr Marcus E.

Publisher

Elsevier BV

Subject

Hematology

Reference38 articles.

1. The hemophilias–from royal genes to gene therapy;Mannucci;N Engl J Med,2001

2. Gene therapy for hemophilia: clinical trials and technical tribulations;Viiala;Semin Thromb Hemost,2009

3. Prophylaxis in people with haemophilia;Coppola;Thromb Haemost,2009

4. Experiences in the prevention of arthropathy in haemophila patients with inhibitors;Jimenez-Yuste;Haemophilia,2008

5. Pierce G. Fusion protein technology-potential treatment for hemophilia. Presentation at WFH Global Forum. September 2009. Montreal, Canada. www wfh org 2009.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shifting Paradigms and Arising Concerns in Severe Hemophilia A Treatment;Seminars in Thrombosis and Hemostasis;2024-01-15

2. Population Pharmacokinetic Analysis of Recombinant Factor VIII Fc Fusion Protein in Subjects With Severe Hemophilia A: Expanded to Include Pediatric Subjects;The Journal of Clinical Pharmacology;2021-04-14

3. BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A;New England Journal of Medicine;2020-09-10

4. BIVV001, a new class of factor VIII replacement for hemophilia A that is independent of von Willebrand factor in primates and mice;Blood;2020-04-23

5. Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications;International Journal of Chronic Obstructive Pulmonary Disease;2018-01